Systemic soluble tumor necrosis factor receptors 1 and 2 are associated with severity of diabetic retinopathy in Hispanics

Ophthalmology

Volumn 119, Issue 5, 2012, Pages 1041-1046

  Kuo, Jane Z ^a   Guo, Xiuqing ^a   Klein, Ronald ^b   Klein, Barbara E ^b   Cui, Jinrui ^a   Rotter, Jerome I ^a   Ipp, Eli ^c   Chen, Yii Der Ida ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE; HEMOGLOBIN A1C; SERUM AMYLOID A; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADULT; ARTICLE; BODY MASS; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; CROSS-SECTIONAL STUDY; DIABETIC RETINOPATHY; DISEASE DURATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EYE PHOTOGRAPHY; FEMALE; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN URINE LEVEL; SYSTOLIC BLOOD PRESSURE;

BLOOD PRESSURE; COHORT STUDIES; CREATINE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HISPANIC AMERICANS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; RISK FACTORS; SERUM AMYLOID A PROTEIN; SEVERITY OF ILLNESS INDEX;

EID: 84862828933     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2011.10.040     Document Type: Article

References (22)

1. Q. Mohamed, M.C. Gillies, T.Y. Wong Management of diabetic retinopathy: a systematic review JAMA 298 2007 902 916 (Pubitemid 47311296)
2. S.K. West, R. Klein, J. Rodriguez Diabetes and diabetic retinopathy in a Mexican-American population: Proyecto VER Diabetes Care 24 2001 1204 1209 (Pubitemid 33716399)
3. X. Zhang, J.B. Saaddine, C.F. Chou Prevalence of diabetic retinopathy in the United States, 2005-2008 JAMA 304 2010 649 656
4. R. Varma, F. Choudhury, R. Klein Los Angeles Latino Eye Study Four-year incidence and progression of diabetic retinopathy and macular edema: the Los Angeles Latino Eye Study Am J Ophthalmol 149 2010 752 761
5. M.I. Harris, R. Klein, C.C. Cowie Is the risk of diabetic retinopathy greater in non-Hispanic blacks and Mexican Americans than in non-Hispanic whites with type 2 diabetes? A U.S. population study Diabetes Care 21 1998 1230 1235 (Pubitemid 28365675)
6. R.B. Goldberg Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications J Clin Endocrinol Metab 94 2009 3171 3182
7. N. Cheung, P. Mitchell, T.Y. Wong Diabetic retinopathy Lancet 376 2010 124 136
8. B.E. Klein, M.D. Knudtson, M.Y. Tsai, R. Klein The relation of markers of inflammation and endothelial dysfunction to the prevalence and progression of diabetic retinopathy: Wisconsin Epidemiologic Study of Diabetic Retinopathy Arch Ophthalmol 127 2009 1175 1182
9. T.T. Nguyen, E. Alibrahim, F.M. Islam Inflammatory, hemostatic, and other novel biomarkers for diabetic retinopathy: the Multi-Ethnic Study of Atherosclerosis Diabetes Care 32 2009 1704 1709
10. Y. Zhao, X. He, X. Shi Association between serum amyloid A and obesity: a meta-analysis and systematic review Inflamm Res 59 2010 323 334
11. G.A. Limb, R.D. Hollifield, L. Webster Soluble TNF receptors in vitreoretinal proliferative disease Invest Ophthalmol Vis Sci 42 2001 1586 1591 (Pubitemid 32520752)
12. G.A. Limb, H. Soomro, S. Janikoun Evidence for control of tumour necrosis factor-alpha (TNF-alpha) activity by TNF receptors in patients with proliferative diabetic retinopathy Clin Exp Immunol 115 1999 409 414 (Pubitemid 29130353)
13. American Diabetes Association Diagnosis and classification of diabetes mellitus Diabetes Care 34 Suppl 2011 S62 S69
14. Early Treatment Diabetic Retinopathy Study Research Group Grading diabetic retinopathy from stereoscopic color fundus photographs - an extension of the modified Airlie House classification ETDRS report number 10 Ophthalmology 98 Suppl 1991 786 806
15. A.D. Meleth, E. Agrón, C.C. Chan Serum inflammatory markers in diabetic retinopathy Invest Ophthalmol Vis Sci 46 2005 4295 4301 (Pubitemid 44264635)
16. D. Fukumura, T. Gohongi, A. Kadambi Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability Proc Natl Acad Sci U S A 98 2001 2604 2609 (Pubitemid 32209529)
17. Y. Kumon, T. Suehiro, T. Itahara Serum amyloid A protein in patients with non-insulin-dependent diabetes mellitus Clin Biochem 27 1994 469 473
18. A.E. Medvedev, T. Espevik, G. Ranges, A. Sundan Distinct roles of the two tumor necrosis factor (TNF) receptors in modulating TNF and lymphotoxin alpha effects J Biol Chem 271 1996 9778 9784 (Pubitemid 26137389)
19. E. Moreau, J. Philippé, S. Couvent, G. Leroux-Roels Interference of soluble TNF-alpha receptors in immunological detection of tumor necrosis factor-alpha Clin Chem 42 1996 1450 1453 (Pubitemid 26300244)
20. G.S. Hotamisligil, N.S. Shargill, B.M. Spiegelman Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance Science 259 1993 87 91 (Pubitemid 23036092)
21. D.E. Moller Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes Trends Endocrinol Metab 11 2000 212 217 (Pubitemid 30603166)
22. J.M. Fernández-Real, M. Broch, W. Ricart Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance Diabetes 47 1998 1757 1762 (Pubitemid 28476250)